Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harue Tada

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
BMC Cancer|August 19, 2011
Quality-of-life evaluation for advanced non-small-cell lung cancer: a comparison between vinorelbine plus gemcitabine followed by docetaxel versus paclitaxel plus carboplatin regimens in a randomized trial: Japan Multinational Trial Organization LC00-03 (BRI LC03-01)Masaaki Kawahara, Harue Tada, Akihiro Tokoro, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|January 21, 2011
A 1-μT extremely low-frequency electromagnetic field vs. sham control for mild-to-moderate hypertension: a double-blind, randomized studyTsutomu Nishimura, Harue Tada, Xinfeng Guo, et al.
BMC Research Notes|August 7, 2009
Interstitial lung disease in gefitinib-treated Japanese patients with non-small cell lung cancer - a retrospective analysis: JMTO LC03-02Masatsugu Nakagawa, Tsutomu Nishimura, Satoshi Teramukai, et al.
Trials|August 11, 2019
The efficacy of a cyclin dependent kinase 9 (CDK9) inhibitor, FIT039, on verruca vulgaris: study protocol for a randomized controlled trialTakashi Nomura, Eriko Sumi, Gyohei Egawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 24, 2010
Medical mushrooms used for biochemical failure after radical treatment for prostate cancer: an open-label studyKoji Yoshimura, Toshiyuki Kamoto, Osamu Ogawa, et al.
Journal of Gastroenterology|November 11, 2025
Long-term outcome of PDT for local failure after CRT or RT for oesophageal cancerTakahiro Horimatsu, Tomonori Yano, Yoshinobu Yamamoto, et al.
World Journal of Surgery|June 10, 2009
Risk factors for complications after laparoscopic surgery in colorectal cancer patients: experience of 401 cases at a single institutionKoya Hida, Takashi Yamaguchi, Hiroaki Hata, et al.
Clinical Drug Investigation|October 5, 2018
Safety and Plasma Concentrations of a Cyclin-dependent Kinase 9 (CDK9) Inhibitor, FIT039, Administered by a Single Adhesive Skin Patch Applied on Normal Skin and Cutaneous WartsEriko Sumi, Takashi Nomura, Ryuta Asada, et al.
Scientific Reports|July 2, 2025
Post hoc analysis of a randomized placebo-controlled trial suggests potential visual benefits of branched-chain amino acids in retinitis pigmentosaTomoko Hasegawa, Hanako Ohashi Ikeda, Hiroyasu Abe, et al.
Translational Vision Science & Technology|August 16, 2024
Efficacy and Safety of Branched Chain Amino Acids on Retinitis Pigmentosa: A Randomized, Double-Blind, Placebo-Controlled Clinical TrialHanako O Ikeda, Tomoko Hasegawa, Hiroyasu Abe, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
BMC Cancer|August 19, 2011
Quality-of-life evaluation for advanced non-small-cell lung cancer: a comparison between vinorelbine plus gemcitabine followed by docetaxel versus paclitaxel plus carboplatin regimens in a randomized trial: Japan Multinational Trial Organization LC00-03 (BRI LC03-01)Masaaki Kawahara, Harue Tada, Akihiro Tokoro, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|January 21, 2011
A 1-μT extremely low-frequency electromagnetic field vs. sham control for mild-to-moderate hypertension: a double-blind, randomized studyTsutomu Nishimura, Harue Tada, Xinfeng Guo, et al.
BMC Research Notes|August 7, 2009
Interstitial lung disease in gefitinib-treated Japanese patients with non-small cell lung cancer - a retrospective analysis: JMTO LC03-02Masatsugu Nakagawa, Tsutomu Nishimura, Satoshi Teramukai, et al.
Trials|August 11, 2019
The efficacy of a cyclin dependent kinase 9 (CDK9) inhibitor, FIT039, on verruca vulgaris: study protocol for a randomized controlled trialTakashi Nomura, Eriko Sumi, Gyohei Egawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 24, 2010
Medical mushrooms used for biochemical failure after radical treatment for prostate cancer: an open-label studyKoji Yoshimura, Toshiyuki Kamoto, Osamu Ogawa, et al.
Journal of Gastroenterology|November 11, 2025
Long-term outcome of PDT for local failure after CRT or RT for oesophageal cancerTakahiro Horimatsu, Tomonori Yano, Yoshinobu Yamamoto, et al.
World Journal of Surgery|June 10, 2009
Risk factors for complications after laparoscopic surgery in colorectal cancer patients: experience of 401 cases at a single institutionKoya Hida, Takashi Yamaguchi, Hiroaki Hata, et al.
Clinical Drug Investigation|October 5, 2018
Safety and Plasma Concentrations of a Cyclin-dependent Kinase 9 (CDK9) Inhibitor, FIT039, Administered by a Single Adhesive Skin Patch Applied on Normal Skin and Cutaneous WartsEriko Sumi, Takashi Nomura, Ryuta Asada, et al.
Scientific Reports|July 2, 2025
Post hoc analysis of a randomized placebo-controlled trial suggests potential visual benefits of branched-chain amino acids in retinitis pigmentosaTomoko Hasegawa, Hanako Ohashi Ikeda, Hiroyasu Abe, et al.
Translational Vision Science & Technology|August 16, 2024
Efficacy and Safety of Branched Chain Amino Acids on Retinitis Pigmentosa: A Randomized, Double-Blind, Placebo-Controlled Clinical TrialHanako O Ikeda, Tomoko Hasegawa, Hiroyasu Abe, et al.
Pageof 5